Overview

Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2022-05-22
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label study to evaluate the safety/tolerability and PK/PD drug-drug interactions between DWP14012 and aspirin when administered in combination.
Phase:
Phase 1
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Treatments:
Aspirin